Download Medical Notes on United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 5 Medical Notes

About This Presentation

Description:United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 is presented in five separate booklets. The report gives an updated overview of recent trends on drug production, drug trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and drug supply. The report also provides the reference point for information on the drug situation worldwide. Booklet 5 of the United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 deals with Cannabis and hallucinogens.

Tags:pharmaceutical companies, R&D, Drug Development, drug supply, drug consumption, illicit drugs, drug demand, Cannabis, hallucinogens

Published on: Jun 30, 2020 | Views : 1648 | Downloads : 1

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

The Pharmaceutical Industry in Europe – Facts and Figure

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

The Pharmaceutical Industry in Europe – Facts and Figure

Specialty Pharmacy and Biosimilars

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.2

Engaging HCPs in Post-Covid-19 Era - Pre-defined Priorities for Pharma Affiliates

2020 US and global life sciences outlook

Pharma 2020 Marketing the future - a paper on the future of the pharmaceutical industry

Tuberculosis

Taming big Pharma

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Coronavirus COVID-19 response for Pharma companies

HEALTH A TO Z